Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK

por Thalange, Nandu, Aldhouse, Natalie Valerie Jane, Kitchen, Helen, Howard, Daniel, Tutkunkardas, Deniz, Håkan-Bloch, Jonas
Publicado 2017

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada

por Johansen, Pierre, Håkan-Bloch, Jonas, Liu, Aiden R., Bech, Peter G., Persson, Sofie, Leiter, Lawrence A.
Publicado 2019

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

por Weatherall, James, Polonsky, William H., Lanar, Sally, Knoble, Naomi, Håkan-Bloch, Jonas, Constam, Elisabeth, Philis-Tsimikas, Athena, Marrel, Alexia
Publicado 2018

Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials

por Jendle, Johan, Birkenfeld, Andreas L., Polonsky, William H., Silver, Robert, Uusinarkaus, Kari, Hansen, Thomas, Håkan‐Bloch, Jonas, Tadayon, Sayeh, Davies, Melanie J.
Publicado 2019